LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.90 | 56.33 | 512 | 4212 | 0.1203 | 0.3628 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.60 | 56.33 | 486 | 4538 | 0.1063 | 0.3424 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.30 | 56.33 | 477 | 4875 | 0.0971 | 0.3334 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.00 | 56.33 | 485 | 5234 | 0.0920 | 0.3261 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.70 | 56.33 | 472 | 5553 | 0.0844 | 0.3073 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.40 | 56.33 | 439 | 5809 | 0.0755 | 0.2706 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.10 | 56.33 | 412 | 6087 | 0.0678 | 0.2498 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 56.80 | 56.33 | 405 | 6354 | 0.0640 | 0.2277 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.50 | 56.33 | 393 | 6599 | 0.0600 | 0.2020 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.20 | 56.33 | 375 | 6852 | 0.0553 | 0.1735 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 61.90 | 56.33 | 358 | 7075 | 0.0512 | 0.1281 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.60 | 56.33 | 353 | 7339 | 0.0486 | 0.1222 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.30 | 56.33 | 346 | 7570 | 0.0464 | 0.1047 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.00 | 56.33 | 333 | 7731 | 0.0440 | 0.0969 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 68.70 | 56.33 | 322 | 7933 | 0.0416 | 0.0922 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.50 | 56.33 | 310 | 7990 | 0.0401 | 0.0683 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 72.20 | 56.33 | 292 | 8053 | 0.0376 | 0.0603 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.90 | 56.33 | 270 | 8150 | 0.0346 | 0.0317 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.60 | 56.33 | 264 | 7992 | 0.0342 | 0.0263 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 77.30 | 56.33 | 252 | 8135 | 0.0325 | 0.0238 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 79.00 | 56.33 | 236 | 8048 | 0.0308 | -0.0056 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.70 | 56.33 | 226 | 7920 | 0.0300 | -0.0287 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.40 | 56.33 | 218 | 7810 | 0.0291 | -0.0379 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.10 | 56.33 | 209 | 7655 | 0.0282 | -0.0543 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 85.80 | 56.33 | 203 | 7583 | 0.0276 | -0.0680 |